Astrazeneca Plc (AZN) Institutional Ownership

Ownership Summary

A total of 662 institutions have reported a stake in Astrazeneca Plc (NASDAQ:AZN) as of December 2025, according to recent 13F filings with the SEC.

• Astrazeneca saw its institutional ownership percentage fell to 2.4% in December 2025 from 31.8% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 9.85%, with a year-over-year a decrease of 45.06% in the count of filers.
• Among the 662 institutional holders of Astrazeneca, 336 added to their stakes while 181 trimmed their positions and 145 held steady.
• This class of investors increased its holdings in Astrazeneca to 37.44Mn shares for the 13F-cycle ending December 2025, up by 3.36Mn shares quarter on quarter, and down 475.22Mn shares year over year.
• With 3.99Mn shares, Swedbank AB commands the largest institutional position in Astrazeneca as of December 31, 2025, equating to 0.26% of the company.
• Among the most significant buyers of Astrazeneca during December 2025 were Bank Julius Baer & Co. Ltd, Zurich (1.79Mn), Allspring Global Investments Holdings, LLC (1.44Mn), TRUIST FINANCIAL CORP (537.91K), UBS Group AG (394.52K), SG Americas Securities, LLC (207.46K).
• Leading sellers of Astrazeneca stock in December 2025 included Phoenix Financial Ltd. (804.92K), ABC ARBITRAGE SA (541.21K), Swedbank AB (375.12K), JENNISON ASSOCIATES LLC (322.82K), MANNING & NAPIER ADVISORS LLC (220.77K).
• The top 10 institutional holders of Astrazeneca for the quarter ending December 2025 included Swedbank AB (3.99Mn), JENNISON ASSOCIATES LLC (3.36Mn), UBS Group AG (2.88Mn), Bank Julius Baer & Co. Ltd, Zurich (1.81Mn), Allspring Global Investments Holdings, LLC (1.63Mn), MANNING & NAPIER ADVISORS LLC (1.54Mn), TRUIST FINANCIAL CORP (1.54Mn), PRINCIPAL FINANCIAL GROUP INC (1.13Mn), NICHOLAS COMPANY, INC. (1.08Mn), Aberdeen Group plc (841.57K).